The 20 Best Non-Alcoholic Fatty Liver Disease Doctors Near Me in Englewood Cliffs, NJ

Dr. Sanjaya K. Satapathy is the medical director of the Center for Liver Disease and Transplantation at the Northwell Transplant Institute, program director of Northwell's Transplant Hepatology Fellowship, and professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.His path to medicine began in India, where he was inspired by his father an engineer with a passion for homeopathy to pursue a career in healthcare. He earned his medical degree from Veer Surendra Sai Medical College, followed by fellowship training in gastroenterology and hepatology in the early 2000s. During that time, he witnessed the profound need for liver transplantation in India, where access remained scarce.While presenting his research at a conference in the United States, Dr. Satapathy was drawn to the opportunities and possibilities for advancing transplantation in America. He decided to continue his career in the United States, completing additional residency and fellowship training before serving as a transplant hepatologist in Memphis. In 2019, he was recruited to Northwell.It was a dream to begin from zero and build a transplant program that could be a model not just for the area or the state, but for the country, says Dr. Satapathy. Within only a few years, we've been able to achieve that goal, because Northwell has all the elements and resources to be one of the best programs in the nation. The expertise we have is unparalleled, with a collaborative team that encompasses all levels of care.The program was founded just in time for a huge surge in demand for liver transplants in the area, he adds. Liver disease and other liver issues are on the rise, making the need for an extensive program crucial for those in the New York region. Part of the program's strength is innovation. For example, Northwell is utilizing an approach that allows donated organs to be safely preserved for a longer period of time, which means needed organs can travel longer distances even from as far away as Hawaii. Northwell is also running several clinical trials on transplant medications and operates a robust transplant hepatology fellowship program to train the next generation of doctors a program Dr. Satapathy launched.I'm passionate about this work, and particularly about my patients, he says. I see every patient as my family, and my focus is on what I can do next to help them. Dr. Satapathy is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Spontaneous Bacterial Peritonitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy. Dr. Satapathy is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Gastroenterology, and American Board Of Internal Medicine/Transplant Hepatology.

Scott Friedman is a Gastroenterologist practicing medicine in New York, New York. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Hepatectomy.

Julia Wattacheril, MD, MPH is an associate professor of medicine, physician scientist, inventor and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. Her clinical and translational work spans the multidisciplinary care of MASLD patients at all stages of their disease to the investigation of rare genetic variants influencing the development and progression of MASLD before and after liver transplantation. She currently leads an interdisciplinary research group using machine learning to identify at-risk and protected phenotypes within the electronic health record (EHR) for multi-omic analysis. Of particular interest for clinical outcomes discovered through EHR phenotyping include rapid progression to advanced liver disease, need for transplantation and hepatocellular carcinoma. Awards include the Department of Surgery Innovation Award and Columbia Department of Biomedical Engineering Ignition Award for these software applications as they move into medicine.Wattacheril is the lead principal investigator for several clinical trials in MASH. Her early pilot work with proteomics and lipidomics in the development of metabolic dysfunction associated steatohepatitis (MASH) led to her current efforts investigating multi-omic signatures associated with fibrotic MASH. She co-led a multicenter consortium investigating the clinical risks associated with the development of hepatocellular carcinoma in patients with all etiologies of chronic liver disease, with a particular local focus on diverse populations. At Columbia, she works closely with the Center for Precision Medicine and Genomics to integrate genomics into clinical care. She mentors across disciplines including computational geneticists to masters’ program students in nutrition to undergraduates in psychology. She has a commitment to community education, including faith-based and non-profit sectors. Dr. Wattacheril is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Enlarged Liver, Liver Transplant, and Endoscopy. Dr. Wattacheril is board certified in Gastroenterology and Transplant Hepatology. Dr. Wattacheril is currently accepting new patients.

Dr. Utpal Pajvani, Associate Professor of Medicine in the Division of Endocrinology at Columbia University, is a physician-scientist with clinical and research focus in Type 2 Diabetes and related metabolic diseases. He graduated from the Massachusetts Institute of Technology with a degree in Biology in 1996, then earned MS (2001), MD (2005) and PhD (Department of Cell Biology, 2005) degrees from the Albert Einstein College of Medicine. Dr. Pajvani completed his internship and residency training and is board certified in Internal Medicine (2007) and fellowship in Endocrinology, Diabetes & Metabolism (2011), both at the Columbia University Medical Center.Dr. Pajvani has been on the faculty of Columbia University since 2011. He is a teaching attending on the inpatient and outpatient Endocrinology and General Medicine services of the New York Presbyterian Hospital, and sees patients at the Naomi Berrie Diabetes Center at Columbia University. Dr. Pajvani is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Obesity, and Type 2 Diabetes (T2D). Dr. Pajvani is board certified in Internal Medicine and Endocrinology, Diabetes And Metabolism. Dr. Pajvani is currently accepting new patients.

Kristina R. Chacko, MD, is an Associate Professor of Medicine at the Albert Einstein College of Medicine in Bronx, NY.  She joined the Einstein-Montefiore Liver Center in 2013 after completing a fellowship in Transplant Hepatology at Mount Sinai School of Medicine in New York, NY.  She received her bachelor of arts in philosophy at Boston College and attended medical school at Baylor College of Medicine in Houston, TX.  She completed her internal medicine residency at Emory University in Atlanta, GA, and gastroenterology fellowship at New York University.  Her clinical and research interests include the diagnosis and management of alcoholic hepatitis, non-alcoholic fatty liver disease, autoimmune liver diseases, and liver transplantation.  As the program director of the ACGME-accredited transplant hepatology fellowship at Montefiore Medical Center, she is directly involved in the development and execution of the hepatology curriculum for gastroenterology and hepatology fellows. Dr. Chacko is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Hepatitis, Visceromegaly, Autoimmune Hepatitis, Hepatitis C, and Liver Transplant.

Mordecai Koenigsberg, MD, is Director of Ultrasound and Director Emeritus of the Diagnostic Residency Program at Montefiore. He is also a Professor of Radiology at our Albert Einstein College of Medicine. Dr. Koenigsberg’s clinical focus is on ultrasound applications in diagnostic imaging. Dr. Koenigsberg is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Ureterocele, Visceromegaly, Scrotal Swelling, and Non-Alcoholic Fatty Liver Disease.

Hillel Tobias is an Internal Medicine specialist and a Transplant Surgeon practicing medicine in New York, New York. Dr. Tobias is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Visceromegaly, Non-Alcoholic Fatty Liver Disease, and Liver Transplant. Dr. Tobias is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Gastroenterology.

Dr. Gendler has been practicing gastroenterology since 1988, and in the Westchester area since joining the staff of White Plains Hospital in 2013. He received his medical degree from Rush Medical College in Chicago and completed his Internal Medicine residency and fellowship training in gastroenterology at St. Luke's Roosevelt Hospital in New York. Immediately after fellowship, Dr. Gendler joined the staff of White Plains Hospital. To further his education, he spent a year as a visiting physician at Erasme Hospital, Universite de Brussels where he learned advanced techniques in lithotripsy for the management of gallstones and diagnostic and therapeutic biliary endoscopy (endoscopic retrograde cholangiopancreaticoscopy). Dr. Gendler is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Trichohepatoenteric Syndrome, Non-Alcoholic Fatty Liver Disease, Visceromegaly, Colonoscopy, and Endoscopy. Dr. Gendler is board certified in American Board Of Internal Medicine.

Jonathan Cohen is a graduate of Harvard College and Harvard Medical School. He completed his residency at Beth Israel Hospital in Boston, and fellowships in gastroenterology at UCLA, and advanced endoscopy at The Wellesley Hospital in Toronto, Canada. Dr. Cohen was Clinical Professor of Medicine at NYU School of Medicine since 2006, joining the full-time faculty as a Professor of Medicine at Northwell/Hofstra in 2024. He has worked as gastroenterologist and performed general and advanced endoscopy at Northwell Vanguard Gastroenterology with expertise in ERCP, colonoscopy, endoscopic resection of large polyps, ablation of tumors and Barrett's esophagus, weight management and endoscopic bariatric therapy. For each of the past 24 years, he has been named to the Castle Connolly Best Doctors list.Dr. Cohen the current Treasurer of the American Society for Gastrointestinal Endoscopy [ASGE] and will be the organization's President in 2027-8. He served as past Chairman of the ASGE Training Committee and the Quality Assurance in Endoscopy Committee. He is also the current Director of the Program for Endoscopic Teachers of the World Endoscopy Organization. Dr. Cohen served as President of the New York Society for Gastrointestinal Endoscopy in 2004. Dr. Cohen has authored numerous articles and has made many presentations at scientific meetings both in the U.S and abroad. He has edited three textbooks in his field: Successful Training in Endoscopy Endoscopy Past Present and Future: NYSGE at 50and Comprehensive Atlas of High-Resolution Endoscopy and Narrowband Imaging, a volume which has been translated into 4 languages and sold worldwide. Dr. Cohen is recognized by his colleagues around the world as an expert on quality indicators in gastroenterology, as well as simulator training and advanced imaging technologies in the early diagnosis of GI cancers. A sought after national and international lecturer, Dr. Cohen has also directed over 50 training courses in his fields of expertise to groups of doctors in many countries and throughout North America. He currently serves as Director of Innovation and Sustainability in the Northwell GI service line. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Gas Bloat Syndrome, Cronkhite-Canada Disease, and Juvenile Polyposis Syndrome. Dr. Cohen is board certified in American Board Of Internal Medicine/Gastroenterology.

Martin Grajower is an Endocrinologist practicing medicine in Riverdale, New York. Dr. Grajower is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Fractured Spine, and Type B Insulin Resistance Syndrome.

Ian Harnik is a Gastroenterologist practicing medicine in Riverdale, New York. Dr. Harnik is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. His clinical expertise encompasses Attenuated Familial Adenomatous Polyposis, Cronkhite-Canada Disease, Juvenile Polyposis Syndrome, Thrombectomy, and Gastrectomy.

Lawrence Brandt is a Gastroenterologist practicing medicine in Bronx, New York. Dr. Brandt is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pseudomembranous Colitis, Irritable Bowel Syndrome (IBS), Viral Gastroenteritis, Colonoscopy, and Endoscopy.

Jack Baldassare is a Radiologist practicing medicine in Fort Lee, New Jersey. Dr. Baldassare is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Nasal Flaring, Thyroid Nodule, Acute Arterial Occlusion of Kidney, and Visceromegaly.

Dr. Angela L. Carrelli is an Assistant Professor of Clinical Medicine in the Division of Endocrinology at Columbia University. She received her undergraduate degree in Chemical Engineering from Princeton University, and earned her M.D. from New York University School of Medicine. Dr. Carrelli completed her internship and residency training in Internal Medicine and her fellowship training in Endocrinology, Diabetes and Metabolism at Columbia University Medical Center. She is board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism, and is an International Society for Clinical Densitometry-certified clinical densitometrist. Dr. Carrelli sees patients in the Metabolic Bone Diseases Program. She also attends on the inpatient Endocrinology consult service and in the outpatient General Endocrine clinic at Columbia University Medical Center. Her research interests include the cardiovascular manifestations of vitamin D deficiency and of primary hyperparathyroidism. Dr. Carrelli is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Melorheostosis, Melorheostosis with Osteopoikilosis, and Parathyroidectomy. Dr. Carrelli is board certified in Internal Medicine and Endocrinology. Dr. Carrelli is currently accepting new patients.

John Bilezikian is an Internal Medicine provider practicing medicine in New York, New York. Dr. Bilezikian is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Hypoparathyroidism, Hypercalcemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).

Harish Guddati is a Gastroenterologist practicing medicine in Bronx, New York. Dr. Guddati is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Gastrointestinal Bleeding, Gallbladder Disease, Cholecystitis, Endoscopy, and Gastrectomy.

Dr. Vargas specializes in Pediatric Endocrinology and is an engaged educator. Dr Vargas joined our faculty in 1998. She has played an active role in the clinical care of pediatric patients with both type 1 and type 2 diabetes at the Naomi Berrie Diabetes Center (NBDC), where she was an integral part in the establishment of its Pediatric component. Her work has focused on curriculum development for patient education in diabetes management and most recently in nutrition education. These efforts include hands-on and virtual cooking demonstrations as well as contributing to the NBDC monthly newsletter topics such as incorporating healthful foods and treats that can help maintain or improve blood sugar control. Dr Vargas participated in the establishment of a Pediatric Obesity Center, now called the Program for Overweight Education and Reduction (POWER) Clinic. She is involved in several ongoing clinical trials; recruiting patients from the community to participate in efforts to promote and study changes in lifestyle and their effect on childhood obesity. Dr. Vargas received a Master of Science in Nutrition at the Institute of Human Nutrition at Columbia University 2/2017. Her thesis research addressed childhood obesity prevention and management in an academic teaching center with a specific focus on resident education. Her findings lead to her involvement in curricular development for the medical student Pediatric Clerkship curriculum in nutrition and obesity which commenced July 2017. She is also co-chairing a committee on Developing a Pediatric Residency Training Curriculum in Nutrition and Obesity since 2018. Dr. Vargas and Dr. John Rausch worked with two residents on their scholarly projects on Culinary Medicine and focusing on the concept of Food as Medicine and are working on integrating their findings to improve outpatient care. In addition, she is involved with Kyle Murray, RD, CDE from NYP-CHALK in giving a monthly nutrition education workshop to the pediatric residents during their outpatient clinical rotation “Social Determinants of Health, Food Insecurity and Introduction to Culinary Medicine” where the residents get to do hands-on cooking demonstrations. She truly feels that Nutrition in our current environment needs to be well taught and that improving our diet quality can prevent and treat diseases such as diabetes. She is currently pursuing a Culinary Medicine Specialist Certification with expected completion spring 2021. Dr. Vargas is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. Her clinical expertise encompasses Type 1 Diabetes (T1D), Nonalcoholic Steatohepatitis (NASH), and Non-Alcoholic Fatty Liver Disease. Dr. Vargas is board certified in Pediatric Endocrinology. Dr. Vargas is currently accepting new patients.

Natasha Leibel is a Pediatric Endocrinologist and a Pediatrics provider practicing medicine in New York, New York. Dr. Leibel is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Diabetic Ketoacidosis, and Nonalcoholic Steatohepatitis (NASH). Dr. Leibel is board certified in Pediatric Endocrinology. Dr. Leibel is currently accepting new patients.

Dr. Jacqueline Lonier is a board-certified endocrinologist specializing in the care of adults with diabetes. She is an Associate Professor of Medicine at Columbia University Irving Medical Center and serves as Associate Director of the Naomi Berrie Diabetes Center, where she leads clinical programs focused on diabetes care. Dr. Lonier has particular expertise in type 1 and type 2 diabetes management, diabetes technology (including insulin pumps and continuous glucose monitoring), atypical diabetes, and diabetes care during pregnancy.Dr. Lonier is an active investigator in multiple NIH- and foundation-funded clinical trials focused on diabetes treatment and technology. She currently serves as site principal investigator for several national studies, including trials of immune therapies for type 1 diabetes, real-world outcomes in people with type 2 diabetes, and novel insulin delivery systems. She is a member of the American Diabetes Association and has served on national advisory committees related to diabetes care.In addition to her clinical and research roles, Dr. Lonier is a dedicated educator and mentor to medical students, residents, and fellows at Columbia. Her approach to patient care emphasizes collaboration, individualized treatment, and a commitment to delivering the highest standard of evidence-based medical care. Dr. Lonier is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Gestational Diabetes. Dr. Lonier is board certified in Endocrinology, Diabetes And Metabolism. Dr. Lonier is currently accepting new patients.

Jee-young Ham is a Pediatric Endocrinologist practicing medicine in New York, New York. Dr. Ham is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. Her clinical expertise encompasses Hypoaldosteronism, Familial Glucocorticoid Deficiency, Triple A Syndrome, and Adrenal Insufficiency Pediatric. Dr. Ham is board certified in Pediatric Endocrinology. Dr. Ham is currently accepting new patients.